Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > squalamine

Squalamine : Genaera : Angiogenesis inhibitor

Squalamine Yields Positive Results in NSCLC (cancernetwork.com)
Oncology News International reports that scientists from Genaera announced positive results for squalamine in a Phase II trial when used with chemotherapy (carboplatin and paclitaxel) in patients with stage IIIB or IV NSCLC. [2002]

Anti-angiogenesis, Squalamine and NSCLC (Genaera)
Describes anti-angiogenesis and explains how squalamine works as an angiogenesis inhibitor. Briefly notes squalamine trial status.

Squalamine - Recent MEDLINE Abstracts (PubMed)


 

Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 18-Feb-2009
Karen Parles, MLS Editor